VRC 605: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy Adults
Clinical trial NCT03015181 · COMPLETED
Trial details
- NCT number
- NCT03015181
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-21
- Primary completion
- 2018-07-10
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.